PFAS–Free Procurement Act of 2025

The PFAS-Free Procurement Act of 2025, HR3110, has been referred to the House Committee on Oversight and Government Reform. This bill mandates that federal agencies prioritize the procurement of products that do not contain per- and polyfluoroalkyl substances (PFAS). This legislative action creates an immediate and direct pressure on manufacturers supplying the federal government to eliminate PFAS from their product lines. Companies that fail to adapt will lose access to a substantial portion of the federal procurement market. Funding for federal procurement is substantial, with the U.S. government being the world's largest single purchaser of goods and services. While HR3110 does not appropriate new funds, it redirects existing procurement spending towards PFAS-free alternatives. Companies that have already invested in PFAS-free research and development, or those with existing PFAS-free product lines, are positioned to capture this redirected spending. Conversely, companies heavily reliant on PFAS in their manufacturing processes face significant capital expenditures for reformulation and retooling, or a direct loss of revenue from federal contracts. Historical precedent for similar environmental procurement shifts exists. For example, the Energy Policy Act of 1992 mandated federal agencies to purchase energy-efficient products. While not directly comparable in scope or chemical specificity, this act demonstrated the government's ability to reshape procurement markets through policy. Companies that adapted early to energy efficiency standards gained a competitive advantage in federal contracting. More recently, the EPA's 2021 PFAS Strategic Roadmap signaled increasing regulatory pressure, leading some companies like 3M ($MMM) to announce exits from PFAS manufacturing by the end of 2025, anticipating future restrictions. Specific losers include major PFAS manufacturers and companies whose products heavily rely on PFAS for performance. 3M ($MMM) is already exiting PFAS manufacturing, but the bill accelerates the pressure on their remaining PFAS-containing product lines until their full exit. DuPont de Nemours ($DD) and Chemours ($CE), both significant producers of fluoropolymers and other PFAS-related chemicals, face direct revenue impacts from reduced demand for their PFAS-containing products from federal agencies. Winners are companies that have developed or can rapidly develop PFAS-free alternatives, particularly in sectors like firefighting foam, textiles, and coatings. Specific companies are not yet publicly identified as dominant PFAS-free solution providers for all federal procurement categories, but those with existing non-fluorinated alternatives will gain market share. HR3110's referral to committee indicates the initial stage of the legislative process. The next step involves committee hearings and potential markups. If it passes committee, it moves to a House floor vote. The timeline for passage is uncertain, but the referral itself signals a clear intent to move forward with PFAS restrictions in federal procurement. Companies should anticipate these changes and accelerate their transition to PFAS-free alternatives now.